Neogen (NEOG) Total Current Liabilities (2011 - 2026)
Neogen's (NEOG) quarterly Total Current Liabilities came in at $150.6 million in Q1 2026, up 6.66% year-on-year from $141.2 million in Q1 2025, and up 2.41% quarter-over-quarter from $147.0 million in Q4 2025.
Neogen (NEOG) Total Current Liabilities (2011 - 2026) Analysis & Trends
Neogen's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $150.6 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 6.66% year-over-year to $150.6 million in Q1 2026; TTM through Feb 2026 was $150.6 million, a 6.66% increase from a year earlier, with the FY2025 full-year figure at $174.0 million, up 12.75% from the prior year.
- Total Current Liabilities improved to $150.6 million in Q1 2026 per NEOG's latest filing, from $147.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $176.6 million in Q4 2023 and bottomed at $65.7 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $146.2 million (2025), against an average of $133.9 million.
- Across the five-year window, Total Current Liabilities jumped 143.42% in 2022 and declined 14.39% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $152.6 million in 2022, then gained by 15.77% to $176.6 million in 2023, then decreased by 14.39% to $151.2 million in 2024, then fell by 2.74% to $147.0 million in 2025, then grew by 2.41% to $150.6 million in 2026.
- Per Business Quant, the three latest NEOG Total Current Liabilities figures stand at $150.6 million (Q1 2026), $147.0 million (Q4 2025), and $146.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | 150.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 150.60 Mn |
| Nov 30, 2025 | 147.05 Mn |
| Aug 31, 2025 | 146.21 Mn |
| May 31, 2025 | 174.00 Mn |
| Feb 28, 2025 | 141.20 Mn |
| Nov 30, 2024 | 151.20 Mn |
| Aug 31, 2024 | 122.69 Mn |
| May 31, 2024 | 154.32 Mn |
| Feb 29, 2024 | 157.84 Mn |
| Nov 30, 2023 | 176.61 Mn |
| Aug 31, 2023 | 138.13 Mn |
| May 31, 2023 | 145.47 Mn |
| Feb 28, 2023 | 107.16 Mn |
| Nov 30, 2022 | 152.56 Mn |
| Aug 31, 2022 | 67.00 Mn |
| May 31, 2022 | 77.84 Mn |
| Feb 28, 2022 | 65.71 Mn |
| Nov 30, 2021 | 62.67 Mn |
| Aug 31, 2021 | 50.76 Mn |
| May 31, 2021 | 53.60 Mn |